Bernie Sanders, Hillary Clinton, and Medicare for All December 20, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman explores the differing positions of presidential candidates Hillary Clinton and Bernie Sanders on a single payer or Medicare-for-all health care system and whether Democratic voters consider it an important factor in the 2016 primaries.
Prescription Drugs’ Sizable Share of Health Spending December 13, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman explains why prescription drug spending may be a larger share of health spending than most people think, depending on how you look at it.
What’s the Political Power of Those Newly Insured Under Obamacare? December 3, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman takes a look at whether the 17 million people newly-insured since 2014 will make an impact in the first presidential election since Affordable Care Act enrollment began.
Why Painkiller Addiction and Abuse Are Rising Health-Care Priorities November 24, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman uses new polling to explore why painkiller abuse and addiction is rising as a health issue among state and federal policymakers.
Health Care and the 2016 Debates November 11, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses the lack of attention to health in the primary debates and last week’s Democratic forum in South Carolina.
GOP Views of Medicaid Expansion Differ From Conventional Wisdom November 4, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman examines Republican attitudes on Medicaid expansion in light of the election of Republican Matt Bevin as Kentucky’s next governor.
The Good and Bad of Those Ubiquitous Drug Ads October 28, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman examines the public’s mixed views about prescription drug ads and their impact on prescribing patterns, based on a new survey.
Covering the Remaining Uninsured: Not Just a Red-State Issue October 14, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman explains why covering the nation’s remaining uninsured population is more than just a red state issue.
Two Substantive Sides to Debate Over Obamacare’s ‘Cadillac Tax’ October 2, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman says debate about whether to keep or repeal the Cadillac tax is more than a debate between sound policy and good politics, there are strong substantive arguments on both sides.
Why Consumer Issues Are Rising on the Health Agenda September 22, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman examines the trends that may be leading to a rise in consumer cost issues on the health agenda.
